How has been the historical performance of Zydus Lifesci.?

Answer:The historical performance of Zydus Lifesci shows a consistent upward trend in net sales and profit over the years, with significant growth observed in the latest fiscal year ending March 2025.

Breakdown:
Zydus Lifesci's net sales increased from 17,237.40 Cr in March 2023 to 23,241.50 Cr in March 2025, reflecting a strong growth trajectory. The total operating income followed a similar pattern, rising to 23,241.50 Cr in March 2025 from 17,237.40 Cr in March 2023. Operating profit (PBDIT) also saw substantial growth, reaching 7,328.00 Cr in March 2025, up from 4,046.50 Cr in March 2023. Profit before tax increased to 6,026.70 Cr in March 2025 from 2,589.70 Cr in March 2023, while profit after tax rose to 4,614.80 Cr from 2,001.90 Cr in the same period. The company’s total assets grew to 34,857.90 Cr in March 2025, up from 24,494.00 Cr in March 2023, indicating a robust asset base. Total liabilities also increased to 34,857.90 Cr in March 2025 from 27,636.60 Cr in March 2024, but the company maintained a zero total debt in March 2025, showcasing improved financial health. Cash flow from operating activities surged to 6,776.00 Cr in March 2025, compared to 2,688.00 Cr in March 2023, contributing to a closing cash balance of 826.00 Cr in March 2025. Overall, Zydus Lifesci has demonstrated strong financial performance with significant growth in sales, profits, and cash flow over the years.